Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001995601-26-000002·Chemomab Therapeutics Ltd.
Schedule 13G ownership disclosure
GALECTO INC
American Depository Shares, each of which represent twenty ordinary shares, no par value · CUSIP: 36322Q107
Event date: 2026-02-10
- Filing-level shares
- 385,000.00
- Percent of class
- 6.3%
- Otto Erik
Shares: 385,000.00 · Class: 6.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001995601-26-000002
- Form type
- SCHEDULE 13G/A
- Filer
- Chemomab Therapeutics Ltd.
- CIK
- CIK 1534248
- Filed
- Feb 10, 2026
- Reporting period
- Feb 10, 2026
- Description
- Schedule 13G beneficial ownership